TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells
Authors:
Open Access
- 19 September 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Abstract
Ovarian cancer (OC) is one of the leading gynecologic cancers worldwide. Cancer stem-like cells are correlated with relapse and resistance to chemotherapy. Twist1, which is involved in ovarian cancer stem-like cell differentiation, is positively correlated with CTNNB1 in different differentiation stages of ovarian cancer cells: primary epithelial ovarian cancer cells (primary EOC cells), mesenchymal spheroid-forming cells (MSFCs) and secondary epithelial ovarian cancer cells (sEOC cells). However, the expression of β-catenin is inversed compared to CTNNB1 in these 3 cell states. We further demonstrated that β-catenin is regulated by the protein degradation system in MSFCs and secondary EOC but not in primary EOC cells. The differentiation process from primary EOC cells to MSFCs and sEOC cells might be due to the downregulation of β-catenin protein levels. Finally, we found that TWIST1 can enhance β-catenin degradation by upregulating Axin2.Keywords
Funding Information
- The National Natural Science Foundation of China (82173376)
- Key Project of Hunan Province 2022 (2022WK2012)
This publication has 77 references indexed in Scilit:
- Normal and disease-related biological functions of Twist1 and underlying molecular mechanismsCell Research, 2011
- Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like charactersBMC Cancer, 2011
- Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysisBMC Cancer, 2011
- TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214Oncogene, 2010
- Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cellsBMC Medical Genomics, 2009
- Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular ProgenitorsStem Cells, 2009
- NV‐128, a novel isoflavone derivative, induces caspase‐independent cell death through the Akt/mammalian target of rapamycin pathwayCancer, 2009
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal TransitionPLOS ONE, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cellsOncogene, 2008